Clinical PET/MR Imaging in Oncology: Future Perspectives.
In 2011, the first fully integrated commercially available clinical PET/MR imaging systems became available, and the imaging community thought that these scanners would replace PET/CT systems. However, today a disappointing number of less than 100 scanners have been installed worldwide. The question, therefore, arises regarding what the future clinical applications of PET/MR imaging will be. In this article, the authors discuss ways in which PET/MR imaging may be used in future applications that justify the added cost, predominantly focusing on oncologic applications. The authors suggest that such areas include combined molecular and functional imaging, multimodality radiomics, and hyperPET.
Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Denmark. Electronic address: akjaer@sund.ku.dk.
Andreas
A
Kjær
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Drew A
DA
Torigian
D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008495:Medical Oncology / Q000379:methods* / Q000639:trends*; D064847:Multimodal Imaging / Q000379:methods*; D009369:Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000379:methods*
Cancer; HyperPET; Molecular imaging; PET/MR imaging